🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6638926

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6635644

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632808

Inhibitors of amyloid formation

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632962

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632945

Inhibitors of P38

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632809

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630447

Peptide inhibitors of LFA-1/ICAM-1 interaction

The Regents of the University of New Mexico · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630464

Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6624166

Pyridazines as interleukin-1&bgr; converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617331

Purine inhibitors of protein kinases, G proteins and polymerases

The Regents of the University of California · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617350

Inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617309

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613743

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613776

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613764

Aspartic protease inhibitors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610684

Fused azepinone cyclin dependent kinase inhibitors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608067

Inhibitors of serine proteases, particularly HCV NS3 protease

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608087

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608060

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6599873

Interleukin-1 inhibitors, compositions, and methods of treatment

The Regents of the University of Colorado · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6596723

Fungal efflux pump inhibitors

Essential Therapeutics, Inc. · Granted Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593357

Pyrazole compositions useful as inhibitors of ERK

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6586475

&bgr;-amyloid protein production/secretion inhibitors

Takeda Chemical Industries Ltd. · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579857

Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired